Porphyrinurias and Occupational Disease
- 1 December 1987
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 514 (1 Mechanis) , 204-218
- https://doi.org/10.1111/j.1749-6632.1987.tb48775.x
Abstract
Pathologic porphyrinuria in man is based on a complex etiology and pathogenesis. In hepatic porphyrias, coproporphyrinuria is usually only one of the pathognomostic porphyrin parameters in the urine. Secondary coproporphyrinuria means that an increased excretion of coproporphyrin occurs as the biochemically dominant symptom of a disturbance in porphyrin and heme metabolism during an intoxication, individual condition, or basic disease. Certain foreign and environmental chemicals, such as hexachlorobenzene, polyhalogenated aromatic hydrocarbons, vinyl chloride, and dioxin, alter the heme pathway functionally. Increased porphyrinuria can follow as a toxic response that is differentiated into secondary coproporphyrinuria and chronic hepatic porphyria. This is characterized by a simultaneous increase in hepatic and urinary uroporphyrin and heptacarboxylic porphyrins, owing to inhibition of hepatic uroporphyrinogen decarboxylase. Most of the coproporphyrinurias observed in man are caused by alcohol ingestion. Dioxin, vinyl chloride, and polyhalogenated biphenyls induce an incipient subclinical stage of chronic hepatic porphyria in persons with normal red cell uroporphyrinogen decarboxylase. In contrast, exposure to dioxin on the part of persons with inherited uroporphyrinogen decarboxylase deficiency can cause latent chronic hepatic porphyria to develop into PCT. Coproporphyrinuria and latent chronic hepatic porphyria do not produce clinical symptoms. Secondary porphyrinuria with transition to chronic hepatic porphyria is a metabolic response following various toxic and pathologic conditions; it serves as a sensitive index for chemical exposure and occupational disease.Keywords
This publication has 29 references indexed in Scilit:
- Urinary Porphyrin Excretion Pattern and Isomer Distribution of I and III in Human Porphyrin Disorders1Published by S. Karger AG ,2015
- Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medicationArchives of Dermatological Research, 1985
- Alcohol and Porphyrin MetabolismPublished by Springer Nature ,1985
- IMMUNOREACTIVE UROPORPHYRINOGEN DECARBOXYLASE IN THE LIVER IN PORPHYRIA CUTANEA TARDAPublished by Elsevier ,1985
- Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred miceBiochemical Journal, 1983
- Pathobiochemical transition of secondary coproporphyrinuria to chronic hepatic porphyria in humansKlinische Wochenschrift, 1980
- Uroporphyrinogen Decarboxylase Deficiency in Experimental Chronic Hepatic PorphyriaHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1980
- HEPATIC DRUG METABOLISM AND HAEM BIOSYNTHESIS IN LEAD‐POISONED RATSBritish Journal of Pharmacology, 1978
- Familial and sporadic porphyria cutaneaHuman Genetics, 1978
- Porphyrinogenic Action of Polyhalogenated Aromatic Compounds, With Special Reference to Porphyria and Environmental ImpactPublished by Springer Nature ,1978